Two network pharmacology studies revealed that CA likely induced anti-osteoporosis and anti-RA actions by modulating specific biological pathways, namely nitrogen metabolism, the estrogen signaling system, the RAP1 signaling pathway, and the PI3K/AKT signaling pathway. Here, AKT1 is linked to rheumatoid arthritis.